Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
Rhea-AI Summary
Exagen Inc. (Nasdaq: XGN), a leader in autoimmune testing solutions, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference. The event is scheduled for August 13-15, 2024, at the InterContinental Boston Hotel in Boston, MA.
John Aballi, Exagen's President and CEO, will engage in a fireside chat on Wednesday, August 14th, at 2:30 PM ET. Interested parties can access the webcast of the presentation through a link available on Exagen's investor relations website.
This participation highlights Exagen's commitment to engaging with investors and showcasing its position in the autoimmune testing market. The conference provides an opportunity for the company to share insights into its growth strategies and recent developments in the field of autoimmune diagnostics.
Positive
- None.
Negative
- None.
News Market Reaction – XGN
On the day this news was published, XGN gained 1.49%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
CARLSBAD, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Canaccord Genuity 44th Annual Growth Conference, which takes place August 13-15, 2024, at the InterContinental Boston Hotel in Boston, MA. John Aballi, Exagen’s President and Chief Executive Officer will participate in a fireside chat on Wednesday, August 14th, at 2:30 PM ET. Interested parties may access the webcast of the presentation using a link on Exagen’s website at https://investors.exagen.com/events.
About Exagen Inc.
Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of improving patients’ clinical outcomes. Exagen is located in San Diego County, California.
For more information, please visit Exagen.com or follow @ExagenInc on X (formerly known as Twitter).
Contact:
Ryan Douglas
Exagen Inc.
ir@exagen.com
760.560.1525
FAQ
When is Exagen Inc. (XGN) participating in the Canaccord Genuity 44th Annual Growth Conference?
Where can I watch the webcast of Exagen's (XGN) presentation at the Canaccord Genuity conference?
What is the main business of Exagen Inc. (XGN)?
Who will represent Exagen Inc. (XGN) at the Canaccord Genuity conference in August 2024?
